HomeALT • NASDAQ
Altimmune Inc
add
$4.41
6.01%
After Hours:(0.68%)+0.030
$4.44
Closed: Apr 11, 7:35:25 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.00K | -86.49% |
Operating expense | 5.09M | 17.50% |
Net income | -23.18M | 26.74% |
Net profit margin | -463.60K | -442.12% |
Earnings per share | -0.33 | -0.33% |
EBITDA | -24.83M | -17.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.89M | -33.33% |
Total assets | 139.31M | -33.87% |
Total liabilities | 15.80M | -4.49% |
Total equity | 123.51M | — |
Shares outstanding | 77.01M | — |
Price to book | 2.43 | — |
Return on assets | -43.29% | — |
Return on capital | -47.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -23.18M | 26.74% |
Cash from operations | -18.27M | -10.48% |
Cash from investing | 13.63M | 271.28% |
Cash from financing | 10.09M | -86.14% |
Net change in cash | 5.45M | -88.70% |
Free cash flow | -9.27M | 7.58% |
Previous close
$4.16
Day range
$4.12 - $4.41
Year range
$3.56 - $11.16
Market cap
339.63M USD
Avg Volume
3.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
59
